Skip to main content
Home

Main navigation

  • About Us
    • About Us
    • Board of Directors
    • Compliance
  • Commitment
    • Innovation Hub
  • Products
    • EXPAREL
    • ioveraº
    • Proprietary Multivesicular Liposome (pMVL) Technology
    • ZILRETTA
  • Partnerships
    • Partnerships for the Future
    • Grants and Corporate Giving
  • News
    • In the News
    • Archive
  • Investors
    • Overview
    • Events
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Investor FAQs
  • Sustainability
  • Careers
Sitemap
  • Home

Site Map

  • About Us
    • About Us
    • Board of directors
    • Compliance
  • Commitment
    • Commitment
    • Innovation hub
  • Products
    • EXPAREL
    • Ioverao
    • pMVL
    • Zilretta
  • Partnerships
    • Partnerships for the Future
    • Grants and Corporate Giving
  • News
    • In the News
    • Archive
  • Investors
    • Overview
    • Events
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Investor FAQs
  • Sustainability
  • Careers
  • Contact Us
  • Legal

The Pacira Website is Intended for US Residents Only

Are you a US Resident?

Yes
No
  • Contact Us
  • Legal
  • Site Map
  • Privacy Notice

EXPAREL® (bupivacaine liposome injectable suspension), ioverao, ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), and Pacira are registered trademarks of the respective subsidiaries of Pacira BioSciences, Inc. All other trademarks referenced herein are the property of their respective owners.

©2023 Pacira Pharmaceuticals, Inc., a wholly owned subsidiary of Pacira BioSciences, Inc.